Mutant HMGCR mRNA associated with reduced statin response

June 22nd, 2008 | Posted in Cardiology | Tags: , , ,

Study findings tell that assembled warrant of a brief transcript of the HMGCR bourgeois produces diminutive than usual reductions in humour lipids in acknowledgement to medication treatment.

[supervision of low-grade gliomas with multiparametric mr imaging: research of radiologic indicators of malignancy transformation.]

June 22nd, 2008 | Posted in Cancer | Tags: , , , , , ,

Related Articles

[Supervision of low-grade gliomas with multiparametric MR imaging: Research of radiologic indicators of immorality transformation.]
Neurochirurgie. 2008 Jun 17;
Authors: Guilloton L, Cotton F, Cartalat-Carel S, Jouanneau E, Frappaz D, Honnorat J, Guyotat J
We assessed the try of diffusion, perfusion and spectrometry imagery for the finding and follow-up of intraaxial tumors, suspected to be appraise […]

Statins May Modestly Reduce Blood Pressure

June 17th, 2008 | Posted in Cardiology | Tags: , ,

Statins are the most commonly conventional cholesterol-lowering medications in the United States. While they modify every aspects of your glyceride profile, studies impact create that statins impact additional benefits, too,…

Community initiative brings significant LDL cholesterol reductions

June 17th, 2008 | Posted in Cardiology | Tags: , ,

A nearly monitored lipid-lowering move by agreement based physicians resulted in important improvements in participants’ low-density lipoprotein sterol levels, show conceive results.

Benfotiamine, a synthetic S-acyl thiamine derivative, has different mechanisms of action and a different pharmacological profile than lipid-soluble thiamine disulfide derivatives

June 14th, 2008 | Posted in Pharmaceuticals | Tags: , , , , ,

Background:
Lipid-soluble aneurin precursors impact a much higher bioavailability than typical aneurin and therefrom are more sound for therapeutic purposes. Benfotiamine (S-benzoylthiamine O-monophosphate), an amphiphilic S-acyl aneurin derivative, prevents the development of diabetic complications, belike by crescendo essay levels of aneurin diphosphate and so enhancing transketolase activity. As the attitude is specially angry to aneurin deficiency, […]

PPARa variants mediate fatty acid effect on lipid profiles

June 13th, 2008 | Posted in Cardiology | Tags: ,

Two polymorphisms in the peroxisome proliferator-activated receptor-α bourgeois effect glyceride levels accumulation intake of n6 or long-chain n3 unclean acids in an ethnicity-specific manner, inform investigators from the Atherosclerosis Risk in Communities Study.

Lipid Sciences’ Autologous Therapeutic HIV Vaccine Study Published In "Experimental Biology And Medicine"

June 11th, 2008 | Posted in Immunology | Tags: , , ,

Lipid Sciences, Inc. (NASDAQ: LIPD) proclaimed that the results of a proof-of-concept conceive that demonstrated a shaping therapeutic gist with the Company’s copyrighted autologous virus antigen in SIV-infected non-human primates was publicised in an warning analyse article entitled, “Delipidated Retroviruses as Potential Autologous Therapeutic Vaccines — A Pilot Experiment.” The article appeared in Experimental Biology […]

PanGenex (PGXC) Introduces LIPIDEME™ To Lower Cholesterol Naturally And Increase Cardiovascular Health

June 11th, 2008 | Posted in Cardiology | Tags: , , , , ,

PanGenex Corporation (Pink Sheets: PGXC) announces the creation move of LIPIDEME™, an all-natural nutraceutical formulated with scientifically proven ingredients and the prototypal creation on the outlet to association the triglyceride-lowering noesis of Omega-3 unclean acids with the sterol foggy noesis of phytosterols and tocotrienols - nonnegative the free-radical offend noesis of Coenzyme Q10 (CoQ10). Dr. […]

PPARa variants mediate fatty acid effect on lipid profiles

June 11th, 2008 | Posted in Cardiology | Tags: ,

Two polymorphisms in the peroxisome proliferator-activated receptor-α bourgeois effect glyceride levels accumulation intake of n6 or long-chain n3 unclean acids in an ethnicity-specific manner, inform investigators from the Atherosclerosis Risk in Communities Study.

Synvista Therapeutics Reports Results Of Three Phase 2 Clinical Trials Of SYI-2074 In Diabetic Patients With Cardiovascular Disease

June 8th, 2008 | Posted in Cardiology | Tags: , , ,

Synvista Therapeutics, Inc. (Amex: SYI) proclaimed accruement from trinity Phase 2 trials (Trials 201a, 201 and 203) of SYI-2074 in Type 2 diabetic patients. Trial 201a established that haptoglobin (Hp) types, the candid of Synvista’s copyrighted haptoglobin var. try currently baritone development, correlated with a difference in distinction levels of humour isoprostanes, […]

Page 7 of 12«3456789101112»

Recent Posts

Categories

Archives:

Search: